Growth Metrics

Novartis Ag (NVS) Cash from Investing Activities (2016 - 2025)

Novartis Ag's Cash from Investing Activities history spans 15 years, with the latest figure at -$2.1 billion for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities rose 48.76% to -$2.1 billion in Q4 2025 year-over-year; TTM through Dec 2025 was -$9.3 billion, a 6.56% decrease, with the full-year FY2025 number at -$4.9 billion, up 35.09% from a year prior.
  • Cash from Investing Activities hit -$2.1 billion in Q4 2025 for Novartis Ag, down from -$860.0 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for NVS hit a ceiling of $5.3 billion in Q4 2021 and a floor of -$11.6 billion in Q2 2022.
  • Historically, Cash from Investing Activities has averaged -$1.7 billion across 5 years, with a median of -$1.1 billion in 2021.
  • Biggest five-year swings in Cash from Investing Activities: surged 1019.79% in 2021 and later tumbled 12087.63% in 2022.
  • Tracing NVS's Cash from Investing Activities over 5 years: stood at $5.3 billion in 2021, then tumbled by 321.4% to -$11.6 billion in 2022, then soared by 90.94% to -$1.1 billion in 2023, then tumbled by 289.93% to -$4.1 billion in 2024, then surged by 48.76% to -$2.1 billion in 2025.
  • Business Quant data shows Cash from Investing Activities for NVS at -$2.1 billion in Q4 2025, -$860.0 million in Q3 2025, and -$2.2 billion in Q2 2025.